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Purpose: To describe the ultrasonographic (US) findings of type IIIa biliary atresia.
Methods: We retrospectively reviewed a medical database of patients pathologically confirmed to 
have biliary atresia, Kasai type IIIa, between January 2002 and May 2013 (n=18). We evaluated 
US findings including the visible common bile duct (CBD), triangular cord thickness, gallbladder 
size and shape, and subcapsular flow on color Doppler US; laboratory data; and pathological 
hepatic fibrosis grades. We divided them into two groups-those with visible (group A) and 
invisible (group B) CBD on US-and compared all parameters between the two groups.
Results: CBD was visible on US in five cases (27.8%; group A) and invisible in 13 cases (72.2%; 
group B). US was performed at an earlier age in group A than in group B (median, 27 days vs. 60 
days; P=0.027) with the maximal age of 51 days. A comparison of the US findings revealed that 
the triangular cord thickness was smaller (4.1 mm vs. 4.9 mm; P=0.004) and the gallbladder 
length was larger (20.0 mm vs. 11.7 mm; P=0.021) in group A. The gallbladder shape did 
not differ between the two groups, and the subcapsular flow was positive in all cases of both 
groups. There was no significant difference in the laboratory data between the two groups. 
Upon pathological analysis, group A showed low-grade and group B showed low- to high-grade 
hepatic fibrosis.
Conclusion: When CBD is visible on US in patients diagnosed with type IIIa biliary atresia, other 
US features could have a false negative status. A subcapsular flow on the color Doppler US 
would be noted in the type IIIa biliary atresia patients.
Keywords: Biliary atresia; Ultrasonography; Common bile duct
Received: March 24, 2014
Revised: May 2, 2014
Accepted: June 10, 2014
Correspondence to:
Myung-Joon Kim, MD, Department 
of Radiology, Research Institute 
of Radiological Science, Severance 
Hospital, Yonsei University College of 
Medicine, 50 Yonsei-ro, Seodaemun-





This is an Open Access article distributed under the 
terms of the Creative Commons Attribution Non-
Commercial License (http://creativecommons.org/
licenses/by-nc/3.0/) which permits unrestricted non-
commercial use, distribution, and reproduction in 
any medium, provided the original work is properly 
cited.
Copyright © 2014 Korean Society of 
Ultrasound in Medicine (KSUM)
How to cite this article: 
Kim SS, Kim MJ, Lee MJ, Yoon CS, Han SJ, Koh H. 
Ultrasonographic findings of type IIIa biliary 
atresia. Ultrasonography. 2014 Oct;33(4):267-
274.
Introduction
Neonatal cholestasis has a variety of underlying causes. However, the two major causes accounting 
for 60%-90% of all neonatal cholestasis are neonatal hepatitis and biliary atresia [1]. Discrimination 
between these two entities is very important, since they require completely different treatment 
approaches-medical treatment for hepatitis and surgery for biliary atresia.
Among the three Kasai types of biliary atresia, type III (porta hepatis obstruction) is the most 
common-accounting for more than 90% of all biliary atresia patients, and has the worst prognosis 
[2-4]. The concept that a younger age at the diagnosis of and surgery for biliary atresia leads to 
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a better outcome has been generally accepted [1,5-14], while 
some of the published data have revealed that patient age has no 
significance or sometimes even a negative effect on the prognosis 
[15,16]. However, when it comes to type III biliary atresia, the 
negative effect of older age seems more obvious [9].
Among non-invasive imaging tools, it is well known that 
ultrasonography (US) has the highest diagnostic accuracy, which 
makes it possible to avoid unnecessary invasive procedures in many 
cases [1,17,18]. Further, many previous studies have reported 
several US findings to diagnose biliary atresia, including a triangular 
cord sign, abnormal gallbladder length and shape, invisible common 
bile duct (CBD), and subcapsular flow on color Doppler US [1,18-
32]. However, some patients show equivocal US findings, requiring 
additional invasive diagnostic methods or leading to a delayed 
diagnosis. In particular, while visible CBD on US is generally regarded 
as a finding suggestive of the disease other than biliary atresia, it 
can be a possible finding of Kasai subtype IIIa (patent distal CBD) 
biliary atresia. Further, there have been only a few reports on the US 
findings of biliary atresia based on its types [33,34]. Therefore, the 




The Institutional Review Board approved this retrospective study 
and waived the requirement of written informed consent from all 
patients.
We retrospectively collected data on patients who were confirmed 
as having biliary atresia by surgical pathology between January 
2002 and May 2013. Further, one pediatric radiologist (MJK) 
reviewed the operative cholecystocholangiography performed 
in these patients, analyzed the Kasai type of biliary atresia, and 
selected type IIIa. A total of 18 patients (10 boys and 8 girls) were 
diagnosed with Kasai type IIIa biliary atresia. We reviewed their US 
findings along with the laboratory and pathological data. Patient 
ages at the US examination were recorded.
Ultrasonography
In our institution, all patients with neonatal cholestasis undergo 
US without being fed for at least 4 hours. A visualization of the 
CBD is recorded, and the triangular cord thickness is measured 
as the thickness of the echogenic anterior wall of the right portal 
vein just proximal to the right portal vein bifurcation site [26]. The 
maximal gallbladder length is measured, and the gallbladder shape 
is evaluated using a high-frequency transducer. When considering 
the gallbladder shape, a discontinuous or absent mucosal lining, 
an indistinct wall, and an irregular outer margin are regarded 
as abnormal. On color Doppler US, a hepatic subcapsular flow 
is evaluated using the color box (height, 1 cm; width, 3-4 cm) 
positioned on the anterior surface around the falciform ligament [23]. 
In some patients, whether normal gallbladder contraction occurs 
after an oral feeding is also evaluated.
Images and Data Review
US findings of invisible CBD, triangular cord thickness of more than 
4 mm, gallbladder length of less than 15 mm, abnormal gallbladder 
shape, and subcapsular flow on color Doppler US are regarded as 
the diagnostic criteria of biliary atresia. We retrospectively reviewed 
and recorded these US findings.
Laboratory data at the time of US were reviewed including total 
and direct serum bilirubin levels, aspartate transaminase (AST), 
alanine transaminase (ALT), gamma-glutamyl transpeptidase (γ
-GT), and alkaline phosphatase (ALP).
Liver wedge biopsy specimens were routinely obtained from 
all the patients at the time of operation. Further, the liver fibrosis 
grades were determined according to the Metavir scoring system as 
follows: F0, no fibrosis; F1, portal fibrosis without septa; F2, portal 
fibrosis and few septa; F3, numerous septa without cirrhosis; F4, 
cirrhosis [35,36].
Statistical Analyses
We divided the patients into two groups on the basis of the US 
finding of CBD-those with visible CBD (group A) and those with 
invisible CBD (group B). All the parameters were compared between 
these two groups.
Categorical parameters such as sex, gallbladder shape on US, 
and subcapsular flow on color Doppler US were compared using 
a Fisher exact test. A Mann-Whitney U test was used to compare 
the continuous variables. Liver fibrosis grades were compared using 
Pearson chi-squared test. Statistical analyses were performed using 
the IBM SPSS ver. 20 (IBM Co., Armonk, NY, USA).
Results
US was performed at the age of 11-100 days with a median of 50 
days in the 18 patients with Kasai type IIIa biliary atresia. CBD was 
visible on US in five cases (27.8%; group A) and invisible in 13 cases 
(72.2%; group B). There were four boys and one girl in group A and 
six boys and seven girls in group B without any difference between 
the two groups (P=0.314). US was performed at an earlier age in 
group A than in group B (median, 27 days vs. 60 days; P=0.027) 
with the maximal age of 51 days (Table 1).
Representative images of US and operative cholangiogram are 
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illustrated in Fig. 1 for group A patients and Fig. 2 for group B 
patients. On the US findings, the triangular cord thickness was 
significantly smaller in group A than in group B (median, 4.1 mm 
vs. 4.9 mm; P=0.004). When considering the cut-off value of the 
triangular cord sign to be 4 mm [26], two patients (2/5, 40%) 
showed a negative triangular cord sign in group A, and all patients 
showed a positive triangular cord sign in group B.
The gallbladder length was larger in group A than that in group 
B (median, 20.0 mm vs. 11.7 mm; P=0.021). When we use the cut-
off value of an atretic gallbladder as 15 mm in length [22], all five 
patients (5/5, 100%) in group A and three patients (3/13, 23%) in 
group B were false negative.
With respect to the gallbladder shape, four cases had a normal 
gallbladder, and only one (1/5, 20%) demonstrated a discontinuous 
mucosal lining in group A. In group B, five cases (5/13, 38%) 
showed an abnormal gallbladder with a discontinuous or absent 
mucosal lining including one case combined with an indistinct wall. 
All gallbladders revealed a smooth outer margin in both groups. 
However, the gallbladder shape was not significantly different 
between the two groups (P=0.615).
Three patients in group A and one patient in group B showed 
normal gallbladder contraction after an oral feeding, while whether 
the gallbladder contracted normally after an oral feeding was not 
evaluated in the remaining 14 patients (not shown in the tables).
On color Doppler US, all patients demonstrated a positive 
subcapsular flow in both groups.
Laboratory and pathological data in the two groups are also 
summarized in Table 1. The application of the upper normal limit 
values used in our institution (total bilirubin, 0.8 mg/dL; direct 
bilirubin, 0.4 mg/dL; γ-GT, 54.0 IU/L; and alkaline phosphatase, 
341 IU/L) increased the total bilirubin, direct bilirubin, and γ-GT in 
all patients of both groups and increased alkaline phosphatase in 
three patients of group A and ten patients of group B. None of the 
laboratory data were significantly different between the two groups. 
In the pathological analysis of liver fibrosis, there were one case 
of F1 and four cases of F2 in group A, while there were nine cases 
Table 1. Comparison between group A (visible CBD) and group B (invisible CBD) of clinical data, ultrasonographic findings, laboratory 
findings, and pathological results
Variable Group A (n=5) Group B (n=13) P-valuea)
Clinical data
     Sex (male: female) 4:1 6:7 0.314
     Age (day) 27 (11-51) 60 (22-100) 0.027
Ultrasonographic findings
     Triangular cord thickness (mm) 4.1 (3.4-4.1) 4.9 (4.0-7.3) 0.004
     Gallbladder length (mm) 20.0 (16.5-23.8) 11.7 (7.2-28.6) 0.021
     Gallbladder mucosal lining: discontinuous/absent 1 (20) 5 (38.5) 0.615
     Gallbladder wall: indistinct 0 1 (7.7) >0.999
     Gallbladder outer margin: irregular 0 0 -
     Positive subcapsular flow 5 (100) 13 (100) -
Laboratory data
     Total bilirubin (mg/dL) 8.7 (4.8-9.6) 7.7 (3.8-18.2) 0.805
     Direct bilirubin (mg/dL) 6.2 (3.3-7.4) 6.3 (2.9-14.7) 0.430
     Aspartate transaminase (IU/L) 57 (49-158) 149 (41-445) 0.084
     Alanine transaminase (IU/L) 37 (34-101) 131 (11-360) 0.104
     γ-glutamyl transpeptidase (IU/L) 270 (109-938) 282 (102-1,055) 0.730
     Alakaline phosphatase (IU/L) 353 (232-505) 490 (298-1,001) 0.218
Pathological data (liver fibrosis grades) 0.246
     F1 1 (20.0) 0
     F2 4 (80.0) 9 (69.2)
     F3 0 2 (15.4)
     F4 0 2 (15.4)
Values are presented as number (%) or median (minimum-maximum value).
CBD, common bile duct.
a) P-values from Mann-Whitney U test for numerical variables and Fisher exact test for categorical variables except for liver fibrosis grades using Pearson chi-squared test.
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Fig. 1. A 27-day-old boy with visible common bile duct (CBD) on ultrasonography (US) 
(group A).
A. Mucosa, wall, and outer margin of the gallbladder look normal. Gallbladder length was 
measured about 20.3 mm. B. After an oral feeding, the gallbladder contracts. C. CBD is 
visible, and its diameter is being measured (crosshairs). D. Triangular cord thickness is 3.4 
mm (crosshairs), which is less than the cut-off value of 4 mm. E. Hepatic subcapsular flow 
is evident on the color Doppler US. F. Operative cholangiogram shows patent CBD (arrow) 
without the filling of the common hepatic duct, confirming type IIIa biliary atresia.
F
D E
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of F2, two cases of F3, and two cases of F4 in group B, showing 
a greater tendency toward the advanced grades of liver fibrosis in 
group B. However, this distinction was not statistically significant 
(P=0.246).
Discussion
There have been many studies on the diagnostic US findings of 
biliary atresia. Tan Kendrick et al. [27] suggested a “gallbladder 
ghost triad” for the diagnostic US findings of biliary atresia-
gallbladder length of <19 mm, indistinct gallbladder wall with a lack 
of a smooth or complete echogenic mucosal lining, and an irregular 
or lobular outer contour. Azuma et al. [21] reported that the absence 
of an extrahepatic bile duct on the US exam can further increase 
the diagnostic accuracy of biliary atresia. Both the triangular cord 
sign and the hepatic subcapsular flow are also known as one of the 
diagnostic US findings of biliary atresia [19,23]. However, not all 
these US findings are always present in patients with biliary atresia.
Mittal et al. [1] stated that CBD can potentially be visible on US 
in certain types of biliary atresia with distal CBD sparing. According 
to the proposal by Kasai et al. [37], biliary atresia with a porta 
hepatis obstruction and patent distal CBD is classified into type IIIa. 
Therefore, patients with type IIIa biliary atresia might show visible 
CBD on US.
There have been only a few reports on the US findings of biliary 
atresia on the basis of its types [33,34]. Further, no study has 
A B C
Fig. 2. A 49-day-old boy with invisible common bile duct (CBD) on ultrasonography (US) (group B).
A. Gallbladder length is 12.8 mm (crosshairs). The mucosal lining and the outer margin of the gallbladder are relatively smooth with a 
distinct wall. Postprandial gallbladder evaluation was not done. B. CBD is invisible in the pancreatic head portion. C. Triangular cord thickness 
is 5.3 mm (crosshairs), which is larger than the cut-off value of 4 mm. D. Hepatic subcapsular flow is evident on the color Doppler US. E. 
Operative cholangiogram shows a patent CBD (arrow) without a visible common hepatic duct, confirming type IIIa biliary atresia.
D E
Seung-seob Kim, et al.
272  Ultrasonography 33(4), October 2014 e-ultrasonography.org
compared the US findings, including the visibility of CBD on US.
Among the 18 patients with type IIIa biliary atresia, CBD was not 
visible in 13 patients even though patent CBD was confirmed on 
operative cholangiography. In our study, one patient showed visible 
CBD at the age of 11 days and was included in group A. However, 
follow-up US, which was not included in this study, was performed 
10 days later, and revealed that CBD was not visible. Therefore, 
one possible explanation for the invisible CBD is that the CBD 
started being affected by the disease process to become too small 
to be seen on US, and still insufficient to cause complete luminal 
obstruction. Another possible explanation is the decreased bile 
flow from the liver caused by the progression of the porta hepatis 
obstruction. This decreased bile flow subsequently causes the 
luminal collapse of CBD, making it difficult to be identified on US.
The triangular cord sign is defined as the triangular cord 
thickness of more than 4 mm [26] and has been proven to be 
highly specific for the diagnosis of biliary atresia by many other 
authors [1,17,18,22,24-26,29]. In contrast, the sensitivity of 
the triangular cord sign has been reported to vary from 14% to 
100% [1,17,22,24-26,29]. Li et al. [28] suggested the following 
three possible explanations for a negative triangular cord sign and 
its low sensitivity: (1) no triangular cord at the porta hepatis, (2) 
triangular cord at the porta hepatis, but too small to be seen, and 
(3) insufficient experience of the US operator. In addition, Saxena 
et al. [38] pointed out that the triangular cord sign may initially be 
negative if the patient is very young and possibly become positive 
later. He reached this conclusion from the observation of a 22-day-
old patient who showed a negative triangular cord sign at the initial 
US and then developed a positive triangular cord sign 2 weeks later.
In our study, group A showed a significantly smaller triangular 
cord thickness than group B, and two patients (2/5, 40%) in group 
A had a negative triangular cord sign, while all patients in group 
B had a positive triangular cord sign. This may be related to the 
suggestion of Saxena et al. [38] since the patient age at the time of 
US was significantly lower in group A than in group B. In particular, 
the two patients with a negative triangular cord sign were of the 
age of 20 days and 27 days, respectively, at the time of US, and 
were considerably younger than the others with a positive triangular 
cord sign.
According to Tan Kendrick et al. [27], all three findings of the 
“gallbladder ghost triad” were constantly positive in 97% of the 
infants with biliary atresia and showed no false positives. Recently, 
several studies have also demonstrated that the small size and 
the abnormal morphology of the gallbladder on US were useful in 
distinguishing biliary atresia from neonatal hepatitis [1,18,30-32]. 
According to our results, the gallbladder length was significantly 
greater in group A than in group B. The use of the cut-off value of 
the atretic gallbladder of 15 mm (length) [22] revealed that all five 
patients (5/5, 100%) in group A and three patients (3/13, 23%) 
in group B were false negative. The evaluation of the gallbladder 
shape was helpful in only one patient (1/5, 20%) of group A 
and five patients (5/13, 38%) of group B. These results are quite 
inconsistent with those of the previous studies on the US features of 
the gallbladder, particularly in group A. One possible explanation is 
that the gallbladder length and shape might be within normal limits 
at an early stage of the disease and become affected as the disease 
progresses, considering the progressive nature of biliary atresia and 
the younger age of group A.
If the gallbladder contracts after an oral feeding, biliary atresia 
is generally considered unlikely [1,39]. However, several authors 
have already reported that normal gallbladder contraction was seen 
after an oral feeding in patients with type IIIa biliary atresia [33,34]. 
In our study, three patients in group A and one patient in group B 
showed normal gallbladder contraction after an oral feeding. In the 
remaining 14 patients, whether the gallbladder contracted normally 
after an oral feeding was not evaluated.
Lee et al. [23] defined a hepatic subcapsular flow as a hepatic 
arterial flow signal continuing to the liver capsular surface on color 
Doppler US and suggested it to be a diagnostic US finding of biliary 
atresia with high sensitivity (100%) and relatively low specificity 
(86%). Recently, El-Guindi et al. [29] supported their findings with 
a sensitivity of 96.3% and a specificity of 96.3%. In our study, the 
subcapsular flow was positive in all patients of both groups and was 
the only finding suggestive of biliary atresia in one patient of group 
A. Therefore, a hepatic subcapsular flow can be used to predict 
biliary atresia even when CBD is visible on US. Furthermore, when 
a hepatic subcapsular flow is not evident, the possibility of biliary 
atresia might be greatly lowered.
It is well known that conjugated hyperbilirubinemia cannot 
reliably discriminate between biliary atresia and neonatal hepatitis 
[40]. Total bilirubin, direct bilirubin, and γ-GT were increased in all 
patients of both groups, and alkaline phosphatase was increased 
in three patients of group A and ten patients of group B. However, 
laboratory data in our study were not statistically different between 
the two groups.
Although pathological liver fibrosis grades were not statistically 
different between the two groups, a tendency towards the advanced 
grades of liver fibrosis was noted in group B. This result is consistent 
with the progressive nature of biliary atresia in causing hepatic 
fibrosis, liver cirrhosis, and eventual liver failure sequentially unless 
appropriate treatment is given [2].
Several limitations of our study should be acknowledged. First, 
the sample size was small, and the sample distribution was uneven 
(group A: n=5 vs. group B: n=13), lowering the reliability of our 
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data. Further studies with larger samples are needed to support our 
results. Second, since it was retrospective study, the pathological 
correlation of the gallbladder and the CBD with their US findings 
could not be established. In order to understand the exact 
underlying mechanisms of the abnormal gallbladder morphology 
and the visibility of the CBD on the US, a correlation between the 
US images and the pathological results should be established in the 
future.
In conclusion, CBD can be either visible or invisible on US in 
patients diagnosed with type IIIa biliary atresia. When CBD was 
visible, other US features with respect to the triangular cord 
thickness and the gallbladder length and shape tended to more 
often show false negative results than when it was invisible. As 
the subcapsular flow on the color Doppler US was always noted 
in patients diagnosed with biliary atresia, Kasai type IIIa, a color 
Doppler study should be included in the routine US examination of 
neonatal cholestasis patients. 
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